Medicare Enrolled
Lai Xu
Hematology & Oncology · Rolling Meadows, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Xu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Xu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Xu
Lai Xu is a hematology & oncology specialist in Rolling Meadows, IL, with 13 years of NPI registration. Based on federal Medicare data, Xu performed 45,993 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Xu received a total of $7,230 from 62 pharmaceutical and/or device companies across 294 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Xu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 22% volume in IL
$7,230 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗45,993
Medicare services
Top 22% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
24,750 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
7,100 | $2 | $9 |
| Injection, granisetron, extended-release, 0.1 mg | 7,100 | $6 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,178 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,038 | $8 | $55 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
666 | $10 | $65 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
538 | $138 | $335 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $97 | $290 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
252 | $89 | $260 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
216 | $11 | $68 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
208 | $109 | $488 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
196 | $13 | $74 |
| Iron level test | 185 | $6 | $50 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
185 | $9 | $35 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
150 | $9 | $40 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
150 | $6 | $48 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
134 | $24 | $135 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
118 | $7 | $55 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
112 | $15 | $80 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
112 | $7 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
109 | $65 | $165 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
106 | $53 | $230 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
92 | $16 | $93 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
83 | $143 | $429 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
75 | $99 | $260 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
74 | $23 | $129 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
58 | $13 | $85 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
57 | $9 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $69 | $190 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
53 | $5 | $30 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
48 | $1 | $7 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
47 | $2 | $19 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
46 | $19 | $100 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 45 | $20 | $134 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $11 | $65 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
43 | $4 | $35 |
| Molecular pathology test interpretation A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report. |
38 | $35 | $65 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
37 | $27 | $189 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
36 | $20 | $200 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
34 | $4 | $20 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
33 | $54 | $249 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
32 | $1 | $6 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $109 | $328 |
| New patient office visit, complex (60-74 min) | 30 | $178 | $495 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $124 | $390 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
55.0% high complexity
35.2% medium
9.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,230
Total received (2018-2024)
Avg $1,033/year across 7 years
Top 35% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
294
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,206
2023
$1,288
2022
$896
2021
$1,660
2020
$430
2019
$265
2018
$485
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$288
AstraZeneca Pharmaceuticals LP
$257
E.R. Squibb & Sons, L.L.C.
$186
Merck Sharp & Dohme LLC
$166
SpringWorks Therapeutics, Inc.
$155
Lilly USA, LLC
$145
Genentech USA, Inc.
$122
Daiichi Sankyo Inc.
$116
Gilead Sciences, Inc.
$83
Celgene Corporation
$68
Astellas Pharma US Inc
$58
GlaxoSmithKline, LLC.
$50
Tempus AI, Inc
$43
PFIZER INC.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$36
Novocure Inc.
$35
ABBVIE INC.
$28
Exelixis Inc.
$27
Deciphera Pharmaceuticals Inc.
$26
Mirati Therapeutics, Inc.
$26
GENZYME CORPORATION
$26
Pharmacosmos Therapeutics Inc.
$25
BeiGene USA, Inc.
$25
Agios Pharmaceuticals, Inc.
$24
Eisai Inc.
$23
Blueprint Medicines Corporation
$23
Iovance Biotherapeutics, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$20
Rigel Pharmaceuticals, Inc.
$19
Genmab U.S., Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Aveo Pharmaceuticals, Inc.
$13
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$729
AstraZeneca Pharmaceuticals LP
$468
Merck Sharp & Dohme Corporation
$438
TG THERAPEUTICS, INC.
$407
Merck Sharp & Dohme LLC
$387
Genentech USA, Inc.
$330
Amgen Inc.
$301
Lilly USA, LLC
$275
E.R. Squibb & Sons, L.L.C.
$270
Seagen Inc.
$264
Astellas Pharma US Inc
$248
Incyte Corporation
$198
Daiichi Sankyo Inc.
$188
Gilead Sciences, Inc.
$176
Celgene Corporation
$160
SpringWorks Therapeutics, Inc.
$155
GENZYME CORPORATION
$129
Janssen Biotech, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$122
PFIZER INC.
$121
Exelixis Inc.
$113
ADC Therapeutics America, Inc.
$110
G1 Therapeutics, Inc.
$97
Myriad Genetic Laboratories, Inc.
$93
BeiGene USA, Inc.
$88
JAZZ PHARMACEUTICALS INC.
$74
Pharmacyclics LLC, An AbbVie Company
$71
Regeneron Healthcare Solutions, Inc.
$69
GlaxoSmithKline, LLC.
$63
Janssen Pharmaceuticals, Inc
$60
Inari Medical, Inc.
$54
ABBVIE INC.
$52
Blueprint Medicines Corporation
$51
Pharmacosmos Therapeutics Inc.
$49
SERVIER PHARMACEUTICALS LLC
$48
Tempus AI, Inc
$43
Karyopharm Therapeutics Inc.
$41
AVEO Pharmaceuticals, Inc.
$36
Novocure Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$33
Puma Biotechnology, Inc.
$31
Stemline Therapeutics Inc.
$30
AMAG Pharmaceuticals, Inc.
$29
AbbVie Inc.
$26
Deciphera Pharmaceuticals Inc.
$26
Mirati Therapeutics, Inc.
$26
Agios Pharmaceuticals, Inc.
$24
Eisai Inc.
$23
ImmunoGen, Inc.
$22
Coherus Biosciences Inc.
$20
Iovance Biotherapeutics, Inc.
$20
CTI BioPharma Corp.
$20
Rigel Pharmaceuticals, Inc.
$19
EMD Serono, Inc.
$18
Genmab U.S., Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Amneal Pharmaceuticals LLC
$17
Apellis Pharmaceuticals, Inc.
$16
TerSera Therapeutics LLC
$15
Dova Pharmaceuticals
$15
Aveo Pharmaceuticals, Inc.
$13
Verastem, Inc.
$12
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Amtagvi · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Elahere · Empaveli · EndoPredict · Enhertu · Epkinly · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · GAVRETO · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · OGSIVEO · OPDIVO · OPDUALAG · Odomzo · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Rezlidhia · S · SARCLISA · SCEMBLIX · TABRECTA · TAGRISSO · TASIGNA · TUKYSA · Tibsovo · Trodelvy · UKONIQ · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XARELTO · XPOVIO · XTANDI · Xermelo · Xtandi · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
274
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWEST COMMUNITY HOSPITAL 1
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Xu is a mixed practice specialist, with above-average Medicare volume (top 22% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Xu experienced with iron infusion (injectafer)?
Based on Medicare claims data, Xu performed 24,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Xu receive payments from pharmaceutical companies?
Yes. Xu received a total of $7,230 from 62 companies across 294 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Xu's costs compare to other hematology & oncology specialists in Rolling Meadows?
Xu's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Xu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rolling Meadows
Browse hematology & oncology specialists in Rolling Meadows ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology